N.E.W. Advisory Services’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36K Hold
97
﹤0.01% 849
2025
Q4
$1.09K Hold
97
﹤0.01% 845
2025
Q3
$1.12K Hold
97
﹤0.01% 787
2025
Q2
$1.19K Hold
97
﹤0.01% 781
2025
Q1
$1.39K Buy
+97
New +$1.51K ﹤0.01% 826

Other funds holding AVNS

N.E.W. Advisory Services's AVNS Position: Q1 2026 in Review

N.E.W. Advisory Services held its Avanos Medical (AVNS) position steady in Q1 2026 at 97 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #849.

N.E.W. Advisory Services first reported a position in AVNS in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.39K in Q1 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • N.E.W. Advisory Services held 97 shares of Avanos Medical worth $1.36K as of Q1 2026.
  • N.E.W. Advisory Services left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of N.E.W. Advisory Services's portfolio in Q1 2026, its #849 holding.
  • N.E.W. Advisory Services first reported a position in Avanos Medical in Q1 2025 and has held it in 5 quarters since.
  • N.E.W. Advisory Services's Avanos Medical position peaked at $1.39K in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on N.E.W. Advisory Services's 13F filing for Q1 2026, filed 5 May 2026.